A compound comprising a first ligand L.sub.A of Formula I,

##STR00001##

is disclosed. In the structure of Formula I, ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z.sup.1-Z.sup.4 are each independently C or N; at least two consecutive Z.sup.1-Z.sup.4 are C, and are fused to a structure of Formula II

##STR00002##

or Formula III

##STR00003##

Y.sup.1; Y.sup.1 and Y.sup.2 are each independently O, S, Se, CRR′, SiRR′, or GeRR′; each R.sup.A, R.sup.B, R.sup.C, R, and R′ is a hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, L.sub.A is complexed to a metal M by the dashed lines in Formula I to form a five-membered chelate ring, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

A compound comprising a first ligand L.sub.A of Formula I,

##STR00001##

is disclosed. In the structure of Formula I, ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z.sup.1-Z.sup.4 are each independently C or N; at least two consecutive Z.sup.1-Z.sup.4 are C, and are fused to a structure of Formula II

##STR00002##

or Formula III

##STR00003##

Y.sup.1; Y.sup.1 and Y.sup.2 are each independently O, S, Se, CRR′, SiRR′, or GeRR′; each R.sup.A, R.sup.B, R.sup.C, R, and R′ is a hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, L.sub.A is complexed to a metal M by the dashed lines in Formula I to form a five-membered chelate ring, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

The present invention relates to compounds of formula (I), which are artemisinin-derivative N-heterocyclic carbene gold (1) hybrid complexes, and to their therapeutic uses.

An organometallic compound represented by Formula 1:

##STR00001##

wherein M.sub.1 and M.sub.2 are each independently a Period 1 transition metal, a Period 2 transition metal, or a Period 3 transition metal in the periodic table of elements; and wherein L.sub.1, L.sub.2, a1, a2, Ar.sub.1, Ar.sub.2, R.sub.1 to R.sub.4, and LK in Formula 1 are as described in the present disclosure.

An organometallic compound represented by Formula 1: ##STR00001##
wherein, in Formula 1, groups and variables are the same as described in the specification.

An organometallic compound represented by Formula 1: ##STR00001##
wherein, in Formula 1, groups and variables are the same as described in the specification.

Provided are an organometallic compound having a novel structure, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

Provided are an organometallic compound having a novel structure, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound.

An organometallic compound represented by Formula 1

##STR00001## wherein, M.sub.1 to M.sub.4 are each independently a first-row transition metal, a second-row transition metal, or a third-row transition metal; X.sub.1 and X.sub.2 are each independently C(R.sub.5)(R.sub.6), Si(R.sub.5)(R.sub.6), N(R.sub.5), O, S, Se, or Te; W.sub.1 to W.sub.4 are each independently N(R.sub.7)(R.sub.8), P(R.sub.7)(R.sub.8), S(R.sub.7), a C.sub.5-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a; L.sub.1 to L.sub.6 are each independently a C.sub.1-C.sub.30 alkylene group unsubstituted or substituted with at least one R.sub.10a, a C.sub.5-C.sub.60 carbocyclic group unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group unsubstituted or substituted with at least one R.sub.10a, a3 to a6 are each independently an integer from 0 to 3, and R.sub.1 to R.sub.8 and R.sub.10a in Formula 1 are as described herein.

Au(III) complexes for [.sup.18F] trifluoromethylation and methods for producing the same are disclosed. A gold complex comprises Au(CF.sub.3).sub.2LR, wherein L comprises a solubility supporting ligand and R comprises an organic substituent. The Au(III) complex can be used to prepare a positron emitting isotope that can be used as tracers for positron emitting tomography (PET) scans.